AAAAAA
Results:
1-9
|
Results: 9
Authors:
Szczech, LA
Citation: La. Szczech, Renal diseases associated with human immunodeficiency virus infection: Epidemiology, clinical course, and management, CLIN INF D, 33(1), 2001, pp. 115-119
Authors:
Reddan, DN
Marcus, RJ
Owen, WF
Szczech, LA
Landwehr, DM
Citation: Dn. Reddan et al., Long-term outcomes of revascularization for peripheral vascular disease inend-stage renal disease patients, AM J KIDNEY, 38(1), 2001, pp. 57-63
Authors:
Szczech, LA
Citation: La. Szczech, Hypertension and medication-related renal dysfunction in the HIV-infected patient, SEM NEPHROL, 21(4), 2001, pp. 386-393
Authors:
Reddan, D
Szczech, LA
Conlon, PJ
Owen, WF
Citation: D. Reddan et al., Contextual issues in comparing outcomes and cave processes for ESRD patients around the world, BLOOD PURIF, 19(2), 2001, pp. 152-156
Authors:
Szczech, LA
Reddan, DN
Owen, WF
Califf, R
Racz, M
Jones, RH
Hannan, EL
Citation: La. Szczech et al., Differential survival after coronary revascularization procedures among patients with renal insufficiency, KIDNEY INT, 60(1), 2001, pp. 292-299
Authors:
Szczech, LA
Lowrie, EG
Li, ZS
Lew, NL
Lazarus, JM
Owen, WF
Citation: La. Szczech et al., Changing hemodialysis thresholds for optimal survival, KIDNEY INT, 59(2), 2001, pp. 738-745
Authors:
Reddan, DN
Szczech, LA
Klassen, PS
Owen, WF
Citation: Dn. Reddan et al., Racial inequity in America's ESRD program, SEMIN DIAL, 13(6), 2000, pp. 399-403
Authors:
Szczech, LA
Reddan, DN
Lowrie, EG
Owen, WF
Citation: La. Szczech et al., Dose of hemodialysis and survival: can we trust important outcomes to a flawed measure?, INT J ARTIF, 23(7), 2000, pp. 411-414
Authors:
Szczech, LA
Feldman, HI
Citation: La. Szczech et Hi. Feldman, Effect of anti-lymphocyte antibody induction therapy on renal allograft survival, TRANSPLAN P, 31(3B), 1999, pp. 9S-11S
Risultati:
1-9
|